#type 2 diabetes

Results from the PREDIMED-Plus trial indicate that a calorie-reduced Mediterranean diet paired with exercise and professional weight-loss support lowered type 2 diabetes risk by 31% over six years.

A Medical Xpress report highlights research suggesting that early increases in glucagon in type 2 diabetes are associated with fatty liver disease, expanding the discussion beyond insulin alone.

Researchers at Helmholtz Munich have built a hybrid obesity therapy that uses GLP-1 and GIP signaling to deliver a second metabolic drug into target cells, producing stronger weight-loss and glucose effects in mice.

A new mouse study from Northwestern University challenges a long-standing assumption about the world’s most widely used type 2 diabetes drug, finding metformin may lower blood sugar primarily by changing how cells in the

A review of 11 major cardiovascular trials found GLP-1 receptor agonists were linked to fewer heart attacks, strokes, and cardiovascular deaths over nearly three years of follow-up, extending the case for the drugs wellb

Researchers at Helmholtz Munich report a new treatment concept that combines GLP-1 and GIP signaling in a single hybrid molecule, with the goal of addressing obesity and type 2 diabetes together.

New research led by Monash University suggests that ordinary movements such as taking the stairs or carrying groceries could play an important role in preventing type 2 diabetes.

Researchers report that 10 genes are linked to hyperemesis gravidarum, with one standing out as a likely main driver, offering new evidence that the severe pregnancy condition has a specific biological basis rather than